Pomalidomide-PEG2-OH

CAS No. 2143097-10-1

Pomalidomide-PEG2-OH ( 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]- )

Catalog No. M28648 CAS No. 2143097-10-1

Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
500MG 2673 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pomalidomide-PEG2-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
  • Description
    Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
  • Synonyms
    1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]-
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CYP2C9;inflammation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2143097-10-1
  • Formula Weight
    361.4
  • Molecular Formula
    C17H19N3O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86.
molnova catalog
related products
  • CNDAC hydrochloride

    CNDAC hydrochloride, a nucleoside analog, is a metabolite of the sapacitabine.

  • Cyclo(Gly-L-Pro)

    Cyclo(Gly-(L)-Pro) shows immunostimulatory properties. Cyclo(Gly-l-Pro) exhibits potent inhibition of TNF-α release with the IC50 values of 4.5 ug/mL, respectively, it also exhibits significant diminution of IL-1β and IL-6 mRNA-expression levels and NO production.

  • MERS-CoV-IN-1

    MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus.It is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS).